Cargando…
Disulfide based prodrugs for cancer therapy
Advances in the tumor microenvironment have facilitated the development of novel anticancer drugs and delivery vehicles for improved therapeutic efficacy and decreased side effects. Disulfide bonds with unique chemical and biophysical properties can be used as cleavable linkers for the delivery of c...
Autores principales: | Wang, Qiang, Guan, Jiankun, Wan, Jiangling, Li, Zifu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055211/ https://www.ncbi.nlm.nih.gov/pubmed/35516223 http://dx.doi.org/10.1039/d0ra04155f |
Ejemplares similares
-
Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy
por: Zhang, Shenwu, et al.
Publicado: (2017) -
Stimulus-responsive self-assembled prodrugs in cancer therapy
por: Dong, Xiao, et al.
Publicado: (2022) -
Self-Assembled Disulfide Bond Bearing Paclitaxel—Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy
por: Gao, Jingyan, et al.
Publicado: (2020) -
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy
por: Xiong, Yuxuan, et al.
Publicado: (2022)